{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:41Z","timestamp":1762876001014},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.diabres.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T23:35:41Z","timestamp":1522107341000},"page":"45-54","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Long-term outcomes associated with triple-goal achievement in patients with type 2 diabetes mellitus (T2DM)"],"prefix":"10.1016","volume":"140","author":[{"given":"Qian","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Krousel-Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2018.02.013_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1478-7954-8-29","article-title":"Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence","volume":"8","author":"Boyle","year":"2010","journal-title":"Popul Health Metr"},{"issue":"4","key":"10.1016\/j.diabres.2018.02.013_b0010","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the U.S. in 2012","volume":"36","author":"American","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2018.02.013_b0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdiacomp.2012.02.001","article-title":"Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27)","volume":"26","author":"Raman","year":"2012","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabres.2018.02.013_b0020","article-title":"Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities","author":"Candrilli","year":"2014","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"10.1016\/j.diabres.2018.02.013_b0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1262-3636(07)70319-1","article-title":"Clinical and metabolic characteristics of newly diagnosed diabetes patients: experience of a university hospital in Tunis","volume":"32","author":"Harzallah","year":"2006","journal-title":"Diabetes Metab"},{"issue":"11","key":"10.1016\/j.diabres.2018.02.013_b0030","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.2337\/dc12-1853","article-title":"Benchmarking is associated with improved quality of care in type 2 diabetes","volume":"36","author":"Hermans","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2018.02.013_b0035","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11606-012-2320-1","article-title":"Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study","volume":"28","author":"Nichols","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.diabres.2018.02.013_b0040","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2337\/dc06-2443","article-title":"Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes","volume":"30","author":"Kong","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2018.02.013_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2337\/dc07-1572","article-title":"Is glycemic control improving in U.S. adults?","volume":"31","author":"Hoerger","year":"2008","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2018.02.013_b0050","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/dc13-0149","article-title":"Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes","volume":"36","author":"Shi","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2018.02.013_b0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.diabres.2018.02.013_b0060","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2018.02.013_b0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/diacare.25.2.275","article-title":"Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial","volume":"25","author":"Rohlfing","year":"2002","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.diabres.2018.02.013_b0070","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models","volume":"32","author":"McCaffrey","year":"2013","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.diabres.2018.02.013_b0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"7134","key":"10.1016\/j.diabres.2018.02.013_b0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2018.02.013_b0085","first-page":"S4","article-title":"Standards of medical care in diabetes\u20132015: summary of revisions","volume":"38","author":"Association","year":"2015","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.diabres.2018.02.013_b0090","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Group","year":"2010","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.diabres.2018.02.013_b0095","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.diabres.2018.02.013_b0100","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2018.02.013_b0105","article-title":"Standards of medical care in diabetes\u20132014","volume":"37","author":"American","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2018.02.013_b0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.diabres.2018.02.013_b0115","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Group","year":"2010","journal-title":"N Engl J Med"},{"issue":"9590","key":"10.1016\/j.diabres.2018.02.013_b0120","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.diabres.2018.02.013_b0125","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.diabres.2018.02.013_b0130","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group AC","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.diabres.2018.02.013_b0135","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study G","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diabres.2018.02.013_b0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.dsx.2014.04.037","article-title":"Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes","volume":"8","author":"Camara","year":"2014","journal-title":"Diabetes Metab Synd: Clin Res Rev"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717304412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717304412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T20:52:02Z","timestamp":1534971122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717304412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":28,"alternative-id":["S0168822717304412"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2018.02.013","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes associated with triple-goal achievement in patients with type 2 diabetes mellitus (T2DM)","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}